Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Scusami who wrote (11216)	11/16/1997 3:06:00 AM
From: Andrew H	Read Replies (2) \| Respond to of 32384

>>LGND has been overdone onthe downside compared to the AMEX BTK average. << I know it has, Scusami. Its gone down about twice as much as the IXB. I am wondering why you use the AMEX BTK index rather that the Nasdaq IXB. DO you think the AMEX is more representative of the group as a whole? Or is it because it seems to track LGND so well? In any case, I sure hope LGND gets back to 15 soon. One would think the LGND would be outperforming, rather than underperforming the averages. Oh, well, according to Henry I have to keep complaining about the low price so the stock will go up. Thanks a lot for the update. Do you see 20 in the cards anytime soon?